Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

United States Cervical Cancer Market Insights, Epidemiology and Market Forecasts 2016-2023 - Research and Markets

Research and Markets
Posted on: 17 Oct 16

Research and Markets has announced the addition of the "Cervical Cancer-Market Insights, Epidemiology and Market Forecast - 2023 - United States" drug pipelines to their offering.

Cervical Cancer- Market Insights, Epidemiology and Market Forecast - 2023 - United States Report provides marketed drugs information of Cervical Cancer. It includes historical and forecasted epidemiology and market size of the Cervical Cancer of US for 2013-2023.

The market size of Cervical Cancer in United States is expected to grow at a Compound Annual Growth Rate of 0.68% and reach up to USD 96.28 million by 2023. The global market size of prophylaxis treatment for Cervical Cancer is expected to grow at a CAGR of 0.71% and reach up to USD 2210.9 Million by 2023.

Cervical Cancer needs to be focused more and more because it adversely affects younger women. It is the fourth most common cause of death among women. Cervical Cancer occurs due to the uncontrolled growth of healthy cells in cervix and forms cervical lesions. It spreads to other tissues such as vagina and uterus. Cervical Cancer is caused by inheritance of defects or mutation in genes.

Key Topics Covered:

  1. Report Introduction
  2. Cervical Cancer Disease Overview
  3. Diagnosis of Cervical Cancer
  4. Epidemiology and Patient Population of Cervical Cancer
  5. Assumptions and Rationale
  6. United States (US)
  7. Treatment Landscape
  8. Treatment Algorithm
  9. Treatment by Stages
  10. Cervical Cancer Treatment Regimens
  11. Current Unmet Needs
  12. Cervical Cancer Emerging therapies Market Size
  13. Side effects of Drug
  14. Cervarix Historical Market Sales 2012-2015
  15. Cost of therapy of Cervarix
  16. Side effects of Drug
  17. Gardasil Historical Market Sales 2012-2015
  18. Cost of therapy of Gardasil
  19. Pipeline Product (Phase III)
  20. Pipeline Product Analysis
  21. Cervical Cancer Therapeutics Market in United States
  22. Cervical Cancer Prophylaxis Treatment Global
  23. Market Drivers
  24. Market Barriers
  25. Appendix

For more information about this drug pipelines report visit

View source version on

Business Wire

Last updated on: 17/10/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.